These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 38337105)
1. Monte Carlo Optimization Method Based QSAR Modeling of Placental Barrier Permeability. Vukomanović P; Stefanović M; Stevanović JM; Petrić A; Trenkić M; Andrejević L; Lazarević M; Sokolović D; Veselinović AM Pharm Res; 2024 Mar; 41(3):493-500. PubMed ID: 38337105 [TBL] [Abstract][Full Text] [Related]
2. The Application of the Combination of Monte Carlo Optimization Method based QSAR Modeling and Molecular Docking in Drug Design and Development. Zivkovic M; Zlatanovic M; Zlatanovic N; Golubović M; Veselinović AM Mini Rev Med Chem; 2020; 20(14):1389-1402. PubMed ID: 32048970 [TBL] [Abstract][Full Text] [Related]
3. The anesthetic action of some polyhalogenated ethers-Monte Carlo method based QSAR study. Golubović M; Lazarević M; Zlatanović D; Krtinić D; Stoičkov V; Mladenović B; Milić DJ; Sokolović D; Veselinović AM Comput Biol Chem; 2018 Aug; 75():32-38. PubMed ID: 29734080 [TBL] [Abstract][Full Text] [Related]
4. Design and development of novel therapeutics for brucellosis treatment based on carbonic anhydrase inhibition. Ničković VP; Mitić NR; Krdžić BD; Krdžić JD; Nikolić GR; Vasić MZ; Ranković G; Babović P; Sokolović D; Veselinović AM J Biomol Struct Dyn; 2020 Apr; 38(6):1848-1857. PubMed ID: 31096856 [TBL] [Abstract][Full Text] [Related]
5. In silico development of potential therapeutic for the pain treatment by inhibiting voltage-gated sodium channel 1.7. Golubovic M; Kostic T; Djordjevic M; Peric V; Lazarevic M; Milic DJ; Marjanovic V; Veselinović AM Comput Biol Med; 2021 May; 132():104346. PubMed ID: 33774271 [TBL] [Abstract][Full Text] [Related]
6. Development and design of novel cardiovascular therapeutics based on Rho kinase inhibition-In silico approach. Ćirić Zdravković S; Pavlović M; Apostlović S; Koraćević G; Šalinger Martinović S; Stanojević D; Sokolović D; Veselinović AM Comput Biol Chem; 2019 Apr; 79():55-62. PubMed ID: 30716601 [TBL] [Abstract][Full Text] [Related]
7. Application of SMILES Notation Based Optimal Descriptors in Drug Discovery and Design. Veselinović AM; Veselinović JB; Živković JV; Nikolić GM Curr Top Med Chem; 2015; 15(18):1768-79. PubMed ID: 25961525 [TBL] [Abstract][Full Text] [Related]
8. Prediction of placental barrier permeability: a model based on partial least squares variable selection procedure. Zhang YH; Xia ZN; Yan L; Liu SS Molecules; 2015 May; 20(5):8270-86. PubMed ID: 25961165 [TBL] [Abstract][Full Text] [Related]
9. Design and development of novel therapeutics for coronary heart disease treatment based on cholesteryl ester transfer protein inhibition - Kostić T; Deljanin Ilić M; Perišić Z; Milić D; Đorđević M; Golubović M; Koraćević G; Šalinger Martinović S; Ćirić Zdravković S; Živić S; Lazarević M; Stanojević D; Dakić S; Lilić J; Veselinović A J Biomol Struct Dyn; 2020 May; 38(8):2304-2313. PubMed ID: 31215331 [TBL] [Abstract][Full Text] [Related]
10. Good and bad molecular fingerprints for human rhinovirus 3C protease inhibition: identification, validation, and application in designing of new inhibitors through Monte Carlo-based QSAR study. Jain S; Amin SA; Adhikari N; Jha T; Gayen S J Biomol Struct Dyn; 2020 Jan; 38(1):66-77. PubMed ID: 30646829 [TBL] [Abstract][Full Text] [Related]
11. In silico development of anesthetics based on barbiturate and thiobarbiturate inhibition of GABA Stošić B; Janković R; Stošić M; Marković D; Stanković D; Sokolović D; Veselinović AM Comput Biol Chem; 2020 Oct; 88():107318. PubMed ID: 32622179 [TBL] [Abstract][Full Text] [Related]
12. Design and development of novel focal adhesion kinase (FAK) inhibitors using Monte Carlo method with index of ideality of correlation to validate QSAR. Kumar P; Kumar A; Sindhu J SAR QSAR Environ Res; 2019 Feb; 30(2):63-80. PubMed ID: 30793981 [TBL] [Abstract][Full Text] [Related]
13. In silico design of diacylglycerol acyltransferase-1 (DGAT1) inhibitors based on SMILES descriptors using Monte-Carlo method. Kumar P; Kumar A; Sindhu J SAR QSAR Environ Res; 2019 Aug; 30(8):525-541. PubMed ID: 31331203 [TBL] [Abstract][Full Text] [Related]
14. In silico prediction of the β-cyclodextrin complexation based on Monte Carlo method. Veselinović AM; Veselinović JB; Toropov AA; Toropova AP; Nikolić GM Int J Pharm; 2015 Nov; 495(1):404-409. PubMed ID: 26320546 [TBL] [Abstract][Full Text] [Related]
15. The Monte Carlo technique as a tool to predict LOAEL. Veselinović JB; Veselinović AM; Toropova AP; Toropov AA Eur J Med Chem; 2016 Jun; 116():71-75. PubMed ID: 27060758 [TBL] [Abstract][Full Text] [Related]
16. Predictive QSAR modeling for the antioxidant activity of natural compounds derivatives based on Monte Carlo method. Ahmadi S; Ghanbari H; Lotfi S; Azimi N Mol Divers; 2021 Feb; 25(1):87-97. PubMed ID: 31933105 [TBL] [Abstract][Full Text] [Related]
17. Use of the Monte Carlo Method for OECD Principles-Guided QSAR Modeling of SIRT1 Inhibitors. Kumar A; Chauhan S Arch Pharm (Weinheim); 2017 Jan; 350(1):. PubMed ID: 28025857 [TBL] [Abstract][Full Text] [Related]
18. Development of QSAR model based on Monte Carlo optimization for predicting GABAA receptor binding of newly emerging benzodiazepines. Antović A; Karadžić R; Živković J; Veselinovic A Acta Chim Slov; 2023 Nov; 70(4):634-641. PubMed ID: 38124634 [TBL] [Abstract][Full Text] [Related]
19. Monte Carlo QSAR models for predicting organophosphate inhibition of acetycholinesterase. Veselinović JB; Nikolić GM; Trutić NV; Živković JV; Veselinović AM SAR QSAR Environ Res; 2015 Jun; 26(6):449-60. PubMed ID: 26043064 [TBL] [Abstract][Full Text] [Related]
20. Can the Monte Carlo method predict the toxicity of binary mixtures? Toropova AP; Toropov AA Environ Sci Pollut Res Int; 2021 Aug; 28(29):39493-39500. PubMed ID: 33755888 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]